A Study of JNJ-64304500 in Participants With Alopecia Areata
Withdrawn before enrolling · Phase 2 · Has a placebo group
Conditions studied: Alopecia Areata
In brief
The purpose of this study is to evaluate the clinical response of 22 weeks of study intervention with JNJ-64304500, compared with placebo, in participants with moderate to severe alopecia areata (AA).
Key facts
- Study ID
- NCT04740970
- Run by
- Janssen Research & Development, LLC
- People needed
- 0
- Starts
- 2021-03-24
- Expected to finish
- 2022-07-20
- Last updated by the study team
- 2021-05-04
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Forcare Clinical Research, Inc. — Tampa, Florida, United States
- Indiana Clinical Trial Center — Plainfield, Indiana, United States
- Dermatology Specialists — Louisville, Kentucky, United States
- Icahn School of Medicine at Mount Sinai — New York, New York, United States
- Columbia University Medical Center — New York, New York, United States
- Oregon Dermatology and Research Center — Portland, Oregon, United States
- University of Pittsburgh Department of Dermatology — Pittsburgh, Pennsylvania, United States
- Modern Research Associates — Dallas, Texas, United States
- Center for Clinical Studies — Webster, Texas, United States
- Sinclair Dermatology — East Melbourne, Australia
- Fremantle Dermatology — Fremantle, Australia
- St George Dermatology & Skin Cancer Centre — Kogarah, Australia
- Veracity Clinical Research — Woolloongabba, Australia
- CHU Bordeaux - Hopital St Andre — Bordeaux, France
- CHU de Nice Hopital de l Archet — Nice, France
- CHU Rouen - Hopital Charles Nicolle — Rouen, France
- Hamamatsu University Hospital — Hamamatsu, Japan
- Kyorin University Hospital — Mitaka, Japan
- Osaka City University Hospital — Osaka, Japan
- The Juntendo Tokyo Koto Geriatric Medical Center — Tokyo, Japan
- Tokyo Medical University Hospital — Tokyo, Japan
- Yamaguchi University Hospital — Ube, Japan
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.